Evolus Corp (EOLS): Narxning daromadga nisbati

Evolus Inc (EOLS) tovar belgisi

Evolus, Inc. (EOLS) qat'iy FDA nazorati va neyrotoksinlarga bo'lgan eksklyuziv huquqlar bilan himoyalangan. Moslashuvchan raqamli marketing kompaniyaga go'zallik bozorini samarali egallashga yordam beradi, yoshlar orasida Jeuveau mahsulotining mashhurligi esa daromadlar o'sishini ta'minlamoqda. GURU.Markets ning narx/savdo ko'rsatkichi grafigi aktiv uchun haddan tashqari ko'p to'lov qilishning oldini olishga yordam beradi, 1.50 esa ushbu parametrning miqdorini aks ettiradi.

Narxning daromadga nisbati: Evolus (EOLS) 04.07.2022 - 13.11.2026 uchun

Jeuveau (EOLS) kompaniyasining tahliliy kesimlari

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Kompaniyaning fundamental tahlili:evolus.com (EOLS)
Evolus, Inc. tayyor mahsulotlari

Evolus, Inc. (EOLS) hamyonbop narxlar va savdoning raqamlashtirilishi orqali sanoat yetakchilari bilan raqobatlashgan holda, neyrotoksin segmentidagi o'z mavjudligini jadal kengtirmoqda. Kompaniyaning P/S koeffitsiyenti dinamikasini tahlil qilish orqali investor daromadning har bir birligining bozor qiymatini baholaydi, bu esa tendentsiya qayrilishlarini o'z vaqtida aniqlash imkonini beradi hamda haddan tashqari qimmat baholangan aktiv uchun ortiqcha to'lov qilish yoki savdo to'xtab qolgan davrda zaiflashayotgan biznesni sotib olishning oldini oladi.

Raqobatdosh kompaniyalar

HCA - Sotuvga nisbatan narx|Narxning daromadga nisbati Tenet Healthcare Corporation THC|Fresenius Medical Care AG - Narxning daromadga nisbati|SOLV: Kapitalizatsiyaning daromadga nisbati|EHC - P/S multiplikatori|uhsinc.com (UHS) - Narxning daromadga nisbati|DVA - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati RDNT|OPCH: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SGRY|Narx/daromad koeffitsiyenti Premier Health|Narxning daromadga nisbati National Vision Holdings EYE|PGNY: Kapitalizatsiya va daromad nisbati|Ardent Health Partners - P/S multiplikatori|Select Medical Corporation (SEM) - Kapitalizatsiyaning daromadga nisbati|ASTH (Apollo Medical Holdings) - Kapitalizatsiyaning daromadga nisbati|MD - Narx/daromad koeffitsiyenti|USPH (US Physical Therapy) - P/S multiplikatori|Sotuvga nisbatan narx pennantgroup.com PNTG|Narxning daromadga nisbati Organogenesis (ORGO)|NUTX - Sotuvga nisbatan narx|Narxning daromadga nisbati Auna Health AUNA|SBC Medical Group Holdings - Narxning daromadga nisbati|CYH - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti The Beauty Health SKIN|MDWD (mediwound.com) - Kapitalizatsiyaning daromadga nisbati|BTMD: Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati The Joint Corporation|DCGO: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori PIII|GANX - Sotuvga nisbatan narx|P/S multiplikatori EUDA (EUDA Health Holdings Limited)|P/S multiplikatori Basel Medical BMGL|CLGN: Kapitalizatsiyaning daromadga nisbati|Cuprina Holdings Limited - Kapitalizatsiyaning sotish hajmiga nisbati|Concord Medical Services (CCM) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati ashs.com|MRM (MEDIROM Healthcare Group) - P/S multiplikatori|Sotuvga nisbatan narx Avalon GloboCare Corporation ALBT|Narxning daromadga nisbati DIH Holding US Inc. (DHAI)|Carmell Corp - Kapitalizatsiya va daromad nisbati|NewGenIvf Group Limited - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati ATIP (ATI Physical Therapy Inc.)|CareMax - P/S multiplikatori|Sotuvga nisbatan narx Kindly MD Inc|MODV (LogistiCare) - Kapitalizatsiyaning daromadga nisbati|NVOS (Novo Integrated Sciences Corp) - Narxning daromadga nisbati|Narxning daromadga nisbati SunLink Health Systems Inc.|Sotuvga nisbatan narx imacholdings.comm BACK